Seaside Therapeutics Site #23 — Kansas City, Kansas

Seaside Therapeutics Site #23 is a clinical research site located in Kansas City, Kansas, United States 66160.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Seaside Therapeutics Site #23 has participated in 1 clinical trials.

Therapeutic areas: Fragile X Syndrome.

Sponsors: Seaside Therapeutics, Inc..

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Seaside Therapeutics Site #23?

Seaside Therapeutics Site #23 has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Seaside Therapeutics Site #23 conducted?

Seaside Therapeutics Site #23 has 1 clinical trials on record. Their work covers Fragile X Syndrome.

Is Seaside Therapeutics Site #23 accredited by Crixeo Health?

Seaside Therapeutics Site #23 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Seaside Therapeutics Site #23?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.